← Back to headlines
Replimune's Advanced Skin Cancer Drug Fails FDA Approval Again
Replimune's drug designed to treat advanced skin cancer has once again failed to receive approval from the FDA.
10 Apr, 16:12 — 10 Apr, 16:12
Sources
Showing 1 of 1 sources
Related Stories
Magnitude 4 Quakes Strike Romania and New Zealand
9h ago
Indonesian Authorities Maintain Alert as Mount Anak Krakatau Continues Erupting
1d ago
Severe Algae Bloom Threatens Israel’s Desalination Infrastructure and Water Supply
1d ago
Ig Nobel Prizes Awarded at First Ceremony Held Outside the United States
2d ago